(SECT-B) Sectra (publ) - Ratings and Ratios
Exchange: ST • Country: Sweden • Currency: SEK • Type: Common Stock • ISIN: SE0018245953
SECT-B: Medical Imaging, Cybersecurity, Secure Communications, IT Systems
Sectra AB (publ) operates at the intersection of medical IT and cybersecurity, offering specialized solutions across Europe, primarily in Sweden, the United Kingdom, the Netherlands, and other European markets. This dual focus positions the company uniquely in two critical sectors, each with its own growth drivers and challenges. Founded in 1957 and headquartered in Linköping, Sweden, Sectra has built a reputation for delivering robust, secure, and innovative solutions tailored to the specific needs of healthcare providers and organizations requiring high-security communication systems.
The company is organized into three distinct business segments: Imaging IT Solutions, Secure Communications, and Business Innovation. The Imaging IT Solutions segment is Sectras largest and most established business, focusing on medical imaging systems that handle, archive, and present medical images and patient data. These systems are designed to integrate seamlessly with existing healthcare infrastructure, offering advanced tools for operational follow-up and radiation dose monitoring. Additionally, this segment provides maintenance and consulting services, including system design and data migration support, which are critical for hospitals and private clinics looking to optimize their IT systems.
The Secure Communications segment addresses the growing demand for secure voice and data communication solutions. This part of the business caters to government agencies, defense departments, and other organizations that require high-security communication systems. Sectras expertise extends to project development, security and threat analysis, and system monitoring services for critical infrastructure. This segment underscores the companys commitment to cybersecurity, a field that has become increasingly important in an era of rising cyber threats and digital espionage.
The Business Innovation segment represents Sectras forward-looking approach to healthcare IT. This division develops and markets IT systems for planning and monitoring orthopedic surgery, as well as products designed for medical education and research projects. By focusing on niche areas within healthcare IT, Sectra demonstrates its ability to identify and address specific pain points in the medical field, positioning itself as a leader in specialized healthcare IT solutions.
From a financial perspective, Sectra AB (publ) offers an interesting profile for investors. With a market capitalization of 48,748.45 million SEK and a price-to-earnings (P/E) ratio of 109.96, the company is valued at a premium, reflecting investor confidence in its long-term growth prospects. The forward P/E of 71.94 suggests that the market expects strong earnings growth in the coming years. The price-to-book (P/B) ratio of 31.52 indicates that investors are willing to pay a significant premium for the companys assets, likely due to its strong market position and intellectual
Additional Sources for SECT-B Stock
SECT-B Stock Overview
Market Cap in USD | 4,828m |
Sector | Healthcare |
Industry | Medical Devices |
GiC Sub-Industry | Pharmaceuticals |
IPO / Inception |
SECT-B Stock Ratings
Growth 5y | 78.1% |
Fundamental | 65.0% |
Dividend | 45.8% |
Rel. Strength Industry | 5.76 |
Analysts | - |
Fair Price Momentum | 226.98 SEK |
Fair Price DCF | 46.54 SEK |
SECT-B Dividends
Dividend Yield 12m | 0.47% |
Yield on Cost 5y | 1.91% |
Annual Growth 5y | 4.10% |
Payout Consistency | 81.9% |
SECT-B Growth Ratios
Growth Correlation 3m | -84.5% |
Growth Correlation 12m | 61.3% |
Growth Correlation 5y | 80.5% |
CAGR 5y | 30.73% |
CAGR/Max DD 5y | 0.57 |
Sharpe Ratio 12m | 1.08 |
Alpha | -1.73 |
Beta | 0.49 |
Volatility | 30.13% |
Current Volume | 113.9k |
Average Volume 20d | 105.5k |
As of March 14, 2025, the stock is trading at SEK 221.25 with a total of 113,888 shares traded.
Over the past week, the price has changed by -3.45%, over one month by -13.86%, over three months by -19.06% and over the past year by +5.51%.
Yes, based on ValueRay Fundamental Analyses, Sectra (publ) (ST:SECT-B) is currently (March 2025) a good stock to buy. It has a ValueRay Fundamental Rating of 65.04 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of SECT-B as of March 2025 is 226.98. This means that SECT-B is currently overvalued and has a potential downside of 2.59%.
Sectra (publ) has no consensus analysts rating.
According to ValueRays Forecast Model, SECT-B Sectra (publ) will be worth about 249.7 in March 2026. The stock is currently trading at 221.25. This means that the stock has a potential upside of +12.86%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 240 | 8.5% |
Analysts Target Price | - | - |
ValueRay Target Price | 249.7 | 12.9% |